$86.41+1.22 (+1.44%)
Market open · as of 10:57 AM ET
Edwards Lifesciences Corp · Overview
Industry: Health Services · see every company filed here →
Edwards Lifesciences Corp scores 58/100. Mixed. Strongest on financial health and quality, value is the soft spot, trading at 49× earnings versus 400 Healthcare peers.
Tenet Score · vs sector
n=400Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value30
Quality71
Health75
Growth55
Factor grades
Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityBHealthBGrowthCMomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Price
Loading chart…
P/E
48.9×
price ÷ trailing EPS, Oct 1, 2026 close
P/B
4.6×
cap ÷ Jun 30, 2026 book value, Oct 1, 2026 close
P/S
8.1×
price to fiscal 2025 sales
ROE
9%
TTM through Jun 30, 2026
Operating margin
20.8%
fiscal 2025, before interest and tax
Net margin
15.4%
TTM through Jun 30, 2026
Current ratio
4.52
Jun 30, 2026 balance sheet
Net debt / EBITDA
−2.6×Tenet-derived Total debt less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year. Computed by Tenet from the filed statements (formula house-nde.v1), because the data vendor published no value for this year.
computed by Tenet from the filed statements
EPS CAGR 5y
+7.1%
trailing 5-year, per share
Market cap
$49.8B
large cap
Div yield
—
no yield on file
52-wk range
72.30 – 96.29
low → high
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
Tenets
2 / 17
- ✓ Buffett Quality
- ~ Piotroski F-Score
- ~ Munger Compounders
- ✕ Magic Formula
- ~ Graham Defensive
- ✕ Lynch GARP
+11 more →
Financials
Revenue, margins and the five-year statements.Analyst Forecasts
Consensus estimates are on the Analyst tab.
Earnings
Report dates and the beat-versus-miss record.Statistics
ROIC9%
Gross margin78%
Debt / equity0.06
Technical Analysis
Mixed short-term signalvs 50-day−3.7%
vs 200-day+0.1%
RSI (14)41
News & Insights
Headlines are on the News tab.Dividends
Pays no dividend. Every dollar of profit is reinvested into the business.Ownership
92% institutional
13F flows & insider trades land here.
About Edwards Lifesciences Corp
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products fo…
Composite computed 2026-10-02 · peer basis: Healthcare (n=400) · every glimpse links to its full section with sources · not investment advice.
ETF exposure
Free account: the funds that hold EW, and at what weight. Everything else on this page stays open.Create a free account